Professional Title & Qualifications:
Chief Physician, MD, PhD, Associate Professor
Specialization:
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Gastric Surgery
Dr. Xiaowen Liu - Surgical Oncologist
Personal Biography
Dr. Xiaowen Liu is a Chief Physician and Associate Professor in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center. With extensive clinical experience in surgical oncology, Dr. Liu is dedicated to the comprehensive treatment of gastric cancer. He holds a medical degree and a PhD, contributing significantly to both clinical practice and academic research in the field of gastrointestinal oncology. Dr. Liu is an active proponent of multidisciplinary team (MDT) approaches to ensure optimal outcomes for patients with advanced gastric malignancies.
Book an online consultation with Dr. Xiaowen Liu
Areas of Expertise
-
Surgical treatment of gastric cancer (Stomach Cancer).
-
Minimally invasive surgery (Laparoscopic and Robotic gastrectomy).
-
Comprehensive multidisciplinary treatment (MDT) for gastric cancer.
-
Management of locally advanced gastric cancer (LAGC).
-
Perioperative chemotherapy and chemoradiotherapy.
-
Diagnosis and treatment of gastric linitis plastica.
Clinical Highlights
-
Over 3,800 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Work Experience
-
Chief Physician, Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
-
Associate Professor, Fudan University Shanghai Cancer Center.
-
Medical Practitioner, Specialized in abdominal surgery and gastric cancer oncology at Fudan University Shanghai Cancer Center.
Research Achievements
-
Principal Investigator/Contact for the PREACT Study (Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery for Locally Advanced Gastric Cancer).
-
Published research on the prognostic significance of tumor markers in gastric cancer.
-
Conducted studies on the role of cancer-associated fibroblasts (CAF) in the tumor microenvironment of gastric cancer.
-
Research on epithelial-mesenchymal transition (EMT) signatures for predicting prognosis and immunotherapy response in gastric cancer.
-
Authored publications in reputable journals such as Oncotarget and Pharmacological Research.
Academic & Social Appointments
-
Member of the Multidisciplinary Team (MDT) for Gastric Cancer at Fudan University Shanghai Cancer Center.
-
Reviewer/Contributor to oncology journals (e.g., Frontiers in Oncology).
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.